Older People's Preventive Care Utilization
Empowering Older People's Preventive Care Utilization Through Mental Model Approach and Patient Activation Approach: a Randomized Control Trial for Promoting Vaccination Uptake
1 other identifier
interventional
270
1 country
1
Brief Summary
Objectives: To empower older people's decision making for taking the recommended vaccines including seasonal influenza vaccines, pneumococcal vaccines, and COVID-19 vaccine (if it is recommended annually). Hypotheses to be tested: The interventions designed using Mental Models Approach and Patient Activation Approach will promote older people's confidence in knowledge and skills regarding vaccination decisions, perceived self-efficacy in self-management of health, positive emotional engagement with vaccination decisions and a positive future time perspective which will subsequently promote their uptake of the recommended vaccines. Design and subjects: This will be a two-arm randomized control trial. Subjects will be community-dwelling older people aged 70 years or above. Instruments: A questionnaire will be used to collect baseline data before the interventions and follow-up data 1 months and 4 months, respectively, after the end of interventions. Interventions: Interventions included one booklet to communicate information about preventive care by bridging expert knowledge and older people's existing mental models, and six patient activation sections conducted over telephone. One patient activation section will be delivered per week by trained medical students. Main outcome measures: Main outcomes will be participants' uptake of the three recommended vaccines assessed at 1 month and 4 months after the end of interventions. Data analysis and expected results: Generalized estimating equation logistic regression will be used to assess the intervention effects. The investigators expect that the interventions can promote at least 20% increase in uptake of any one of the three recommended vaccines in the intervention group compared with the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2022
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedMarch 30, 2025
March 1, 2025
8 months
December 28, 2022
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Uptake Rate of the Three Recommended Vaccines from Baseline to within 1 Month and 4 Months after Interventions
Participants' uptake rate of the three recommended vaccines (influenza vaccines, pneumococcal vaccines, and COVID-19 vaccines).
Assessed at baseline, within 1 month and 4 months after the end of interventions.
Secondary Outcomes (5)
Changes in Patient Activation Measure from baseline to within 1 month after intervention ends
At baseline and within one month after the end of the intervention (in the 1st follow-up assessment)
Changes in Emotional engagement with vaccination decisions measurement from baseline to within 1 month after intervention ends
At baseline and within one month after the end of the intervention (in the 1st follow-up assessment)
Changes in Future time perspective measurement from baseline to within 1 month after intervention ends
At baseline and within one month after the end of the intervention (in the 1st follow-up assessment)
Changes in lifestyle behaviours from baseline to within 1 month and 4 months after intervention ends
At baseline and within one month (in the 1st follow-up assessment) and four months (2nd outcome assessment)after the end of the intervention
Changes in other preventive care utilization from baseline to within 1 month and 4 months after intervention ends
At baseline and within one month (in the 1st follow-up assessment) four months (2nd outcome assessment) after the end of the intervention
Study Arms (2)
Control Group
ACTIVE COMPARATORParticipants who are allocated to the control group will receive a pamphlet about recommendation for influenza vaccines, pneumococcal vaccines, and COVID-19 vaccines (if appropriate) for older people using information from Hong Kong Department of Health. This group will receive six control telephone care visits over six weeks. We will purposively balance the characteristics of the student helpers who do the control telephone visits and the patient activation interviews. Each control telephone care visit will be around 5-10 min during which the student helper will give general guidelines about dietary health and exercise for older people. The control messages are mainly educational and designed using information derived from the websites of Hong Kong Department of Health. In the last telephone care visit, the interviewer will give a summary for how to live a healthy lifestyle and a reminder of taking the recommended vaccinations for older people shown in the pamphlet.
Intervention Group
EXPERIMENTALIntervention development and delivery The interventions will involve deliver a booklet designed based on MMA and six telephone interviews for patient activation. Design of booklet for older people's preventive care: The booklet will be framed as one series of "Positive aging via preventive care"-vaccination. According to MMA, the booklet will be aimed to translate expert knowledge into information that can fit to older people's mental models (e.g., misperceptions and knowledge deficits revealed in our previous qualitative studies) regarding vaccinations to facilitate cognitive process of the information. Patient activation sections: We will design six telephone-based patient activation sections with accommodation for older people's mental models and decision-making preference. The motivation interviewing (MI) techniques will be incorporated into the design of patient activation sections.
Interventions
Design of booklet for older people's preventive care: We propose that the booklet will include 8 main topics based on what experts and current academic literature believe are important for encouraging older people's preventive care utilization. To add the social norms-related cues for the later three topics of the booklet, one qualitative study on older adults who are active in preventive care is needed. Therefore, we will interview \~20 older adults aged 70 years or above who are active in taking preventive care. We will conduct one-to-one in-depth interview to explore how participants overcome difficulties during decision making for vaccination and their positive feelings after making achievements. We will also explore and identify older adults who have a positive future perspective. Patient activation sections: . Four undergraduate medical students will be trained as the coaches to deliver the patient activation sections over six weeks. Each section will be around 20 min.
Participants in the control group will receive a pamphlet about recommendation for influenza, pneumococcal, and COVID-19 vaccines (if appropriate) for older people using information from Hong Kong Department of Health. As a control for the patient activation interviews, the control group will also be informed that they will join our "telephone-based elderly care project" by the end of the baseline assessment but instead of receiving the patient activation interviews, this group will receive six control telephone care visits over six weeks. Each control telephone care visit will be around 5-10 min during which the student helper will give general guidelines about dietary health and exercise for older people. The control messages are mainly educational and designed using information derived from the websites of Hong Kong Department of Health.
Eligibility Criteria
You may qualify if:
- Community-dwelling older persons aged 70 years who did not persistently receive seasonal influenza vaccine over the past three years (2020-2022) and/or have never received the pneumococcal vaccine (one dose of the 23-valent pneumococcal polysaccharide vaccine (23vPPV) or the 13-valent pneumococcal conjugate vaccine (PCV13)).
- Being able to communicate with Cantonese, or Mandarin (the two main spoken language in Hong Kong) and being able to read Chinese.
You may not qualify if:
- having psychiatric disorders, dementia, or other cognitive difficulties which impede communication or understanding of the intervention and having functional disabilities which impede access to health care services.
- subjects who had medical contraindications for immunization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Public Health, The University of Hong Kong
Hong Kong, China, HKG, Hong Kong
Related Publications (25)
United Nations Development Programme. Human development report 2013: the rise of the South: human progress in a diverse world. 2013 [Available from: https://hdr.undp.org/en/global-reports.
BACKGROUNDWong K, Yeung M. Population aging trend of Hong Kong: Office of the Government Economist, The Government of the Hong Kong Special Administrative Region; 2019 [Available from: https://www.hkeconomy.gov.hk/en/pdf/el/el-2019-02.pdf.
BACKGROUNDHong Kong Census and Statistics Department. Thematic Household Survey Report No. 40: socio-demographic profile, health status and self-care capability of older persons. 2009 [Available from: https://www.censtatd.gov.hk/en/data/stat_report/product/C0000071/att/B11302402009XXXXB0100.pdf.
BACKGROUNDMytton OT, Jackson C, Steinacher A, Goodman A, Langenberg C, Griffin S, Wareham N, Woodcock J. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study. PLoS Med. 2018 Mar 6;15(3):e1002517. doi: 10.1371/journal.pmed.1002517. eCollection 2018 Mar.
PMID: 29509767BACKGROUNDJefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005 Oct 1;366(9492):1165-74. doi: 10.1016/S0140-6736(05)67339-4. Epub 2005 Sep 22.
PMID: 16198765BACKGROUNDYin M, Huang L, Zhang Y, Yu N, Xu X, Liang Y, Ni J. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines. 2018 Jul;17(7):653-663. doi: 10.1080/14760584.2018.1495077. Epub 2018 Jul 16.
PMID: 29961353BACKGROUNDHong Kong Department of Health. Report of Population Health Survey 2014/2015 2017 [Available from: https://www.chp.gov.hk/files/pdf/dh_phs_2014_15_full_report_eng.pdf.
BACKGROUNDHong Kong Center for Health Protection. Statistics on vaccination programmes in the past 3 years 2022 [Available from: https://www.chp.gov.hk/en/features/102226.html.
BACKGROUNDHong Kong Center for Health Protection. COVID-19 vaccination programme: Hong Kong Vaccination Dashboard: The Government of the Hong Kong Special Administrative Region; 2022 [Available from: https://www.covidvaccine.gov.hk/en/dashboard.
BACKGROUNDBadham SP, Hamilton CA. Influences of Complexity on Decision Making in Young and Older Adults. Eur J Psychol. 2020 May 29;16(2):280-299. doi: 10.5964/ejop.v16i2.1958. eCollection 2020 May.
PMID: 33680183BACKGROUNDPeters E, de Bruin WB. Aging and decision skills. In: Dhami MK, Schlottmann A, Waldmann MR, editors. Judgment and decision making as a skill: learning, development and evolution: Cambridge University Press; 2012. p. 113-39.
BACKGROUNDFinucane ML, Gullion CM. Developing a tool for measuring the decision-making competence of older adults. Psychol Aging. 2010 Jun;25(2):271-88. doi: 10.1037/a0019106.
PMID: 20545413BACKGROUNDCarstensen LL. The influence of a sense of time on human development. Science. 2006 Jun 30;312(5782):1913-5. doi: 10.1126/science.1127488.
PMID: 16809530BACKGROUNDReinhardt A, Rossmann C. Age-related framing effects: Why vaccination against COVID-19 should be promoted differently in younger and older adults. J Exp Psychol Appl. 2021 Dec;27(4):669-678. doi: 10.1037/xap0000378. Epub 2021 Jul 22.
PMID: 34292048BACKGROUNDLiu X, Ji L, Peng H. The impacts of task relevance and cognitive load on adults' decision information search. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 Jan;28(1):78-96. doi: 10.1080/13825585.2020.1712320. Epub 2020 Jan 11.
PMID: 31928164BACKGROUNDBruine de Bruin W, Parker AM, Fischhoff B. Individual differences in adult decision-making competence. J Pers Soc Psychol. 2007 May;92(5):938-956. doi: 10.1037/0022-3514.92.5.938.
PMID: 17484614BACKGROUNDLiao Q, Lau W, McGhee S, Yap M, Sum R, Liang J, Lian J. Barriers to preventive care utilization among Hong Kong community-dwelling older people and their views on using financial incentives to improve preventive care utilization. Health Expect. 2021 Aug;24(4):1242-1253. doi: 10.1111/hex.13256. Epub 2021 May 5.
PMID: 33949749BACKGROUNDRonnlund M, Del Missier F, Mantyla T, Carelli MG. The Fatalistic Decision Maker: Time Perspective, Working Memory, and Older Adults' Decision-Making Competence. Front Psychol. 2019 Sep 12;10:2038. doi: 10.3389/fpsyg.2019.02038. eCollection 2019.
PMID: 31572258BACKGROUNDStrough J, de Bruin WB, Peters E. New perspectives for motivating better decisions in older adults. Front Psychol. 2015 Jun 22;6:783. doi: 10.3389/fpsyg.2015.00783. eCollection 2015.
PMID: 26157398BACKGROUNDBruine de Bruin W, Bostrom A. Assessing what to address in science communication. Proc Natl Acad Sci U S A. 2013 Aug 20;110 Suppl 3(Suppl 3):14062-8. doi: 10.1073/pnas.1212729110. Epub 2013 Aug 13.
PMID: 23942122BACKGROUNDHibbard JH, Mahoney E. Toward a theory of patient and consumer activation. Patient Educ Couns. 2010 Mar;78(3):377-81. doi: 10.1016/j.pec.2009.12.015. Epub 2010 Feb 25.
PMID: 20188505BACKGROUNDHibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007 Aug;42(4):1443-63. doi: 10.1111/j.1475-6773.2006.00669.x.
PMID: 17610432BACKGROUNDBandura A. Self-Efficacy. The Corsini Encyclopedia of Psychology. p. 1-3.
BACKGROUNDSinclair AH, Stanley ML, Hakimi S, Cabeza R, Adcock RA, Samanez-Larkin GR. Imagining a Personalized Scenario Selectively Increases Perceived Risk of Viral Transmission for Older Adults. Nat Aging. 2021 Aug;1(8):677-683. doi: 10.1038/s43587-021-00095-7. Epub 2021 Aug 5.
PMID: 35990532BACKGROUNDDobler A, Herbeck Belnap B, Pollmann H, Farin E, Raspe H, Mittag O. Telephone-delivered lifestyle support with action planning and motivational interviewing techniques to improve rehabilitation outcomes. Rehabil Psychol. 2018 May;63(2):170-181. doi: 10.1037/rep0000224.
PMID: 29878825BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 28, 2022
First Posted
January 20, 2023
Study Start
October 1, 2024
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
March 30, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- After the study findings are published, an anonymous dataset will be created and managed by the PI from this project and made publicly accessible upon reasonable request by other research PIs for the purpose of research use only. The data will be available for 10 years after publishing.
- Access Criteria
- For research use only.
Only the Principal Investigator (PI) and the designated research assistant of the research project will have access to the personal data during and after the study. After the study findings are published, an anonymous dataset will be created and managed by the PI from this project and made publicly accessible upon reasonable request by other research PIs for the purpose of research use only. PI will be responsible for safekeeping of the personal data during and after the study.